期刊文献+

Successful treatment with rifampin for fulminant antibiotics-associated colitis in a patient with non-Hodgkin's lymphoma

Successful treatment with rifampin for fulminant antibiotics-associated colitis in a patient with non-Hodgkin's lymphoma
下载PDF
导出
摘要 A 74-year-old man was admitted to the hospital because of chemotherapy for relapsed non-Hodgkin's lymphoma (NHL).The patient became febrile and experienced diarrhea after chemotherapy. Although ceftazidime and amikacin sulfate were administered as empiric therapy, diarrhea was continued.After several days, stool cytotoxin assay for clostridium difficile (C. difficile) was positive and he was diagnosed as having antibiotics-associated colitis (AAC). Although antibiotics were discontinued and both oral vancomycin and metronidazole were administrated, disease was not improved. To rule out the presence of an additional cause of diarrhea, colon fiberoscopic examination was performed. It revealed multiple deep ulcerative lesions at right side colon, surface erosive and minute erosive lesions in all continuous colon.Pseudomembranes were not seen. These findings are compatible with AAC without pseudomembranes. There are no reports that the rifampin is effective on refractory AAC.However, we administered oral rifampin for the current patient.The reasons are 1) conventional antibiotics were not effective,2) rifampin has excellent in vitro activity against C. difficile,and 3) the efficacy of rifampin on relapsing colitis due to C.difficile is established. After administration of rifampin, fever alleviated and diarrhea was improved. Because AAC may result in significant mortality, patients with refractory or fulminant AAC should be treated with oral rifampin from outset. A 74-year-old man was admitted to the hospital because of chemotherapy for relapsed non-Hodgkin's lymphoma(NHL). The patient became febrile and experienced diarrhea after chemotherapy.Although ceftazidime and amikacin sulfate were administered as empiric therapy,diarrhea was continued. After several days,stool cytotoxin assay for clostridium difficile (C.difficile)was positive and he was diagnosed as having antibiotics-associated colitis(AAC).Although antibiotics were discontinued and both oral vancomycin and metronidazole were administrated,disease was not improved.To rule out the presence of an additional cause of diarrhea,colon fiberoscopic examination was performed.It revealed multiple deep ulcerative lesions at right side colon,surface erosive and minute erosive lesions in all continuous colon. Pseudomembranes were not seen.These findings are compatible with AAC without pseudomembranes.There are no reports that the rifampin is effective on refractory AAC. However,we administered oral rifampin for the current patient. The reasons are 1)conventional antibiotics were not effective, 2)rifampin has excellent in vitro activity against C.difficile, and 3)the efficacy of rifampin on relapsing colitis due to C. difficile is established.After administration of rifampin,fever alleviated and diarrhea was improved.Because AAC may result in significant mortality,patients with refractory or fulminant AAC should be treated with oral rifampin from outset.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2004年第5期765-766,共2页 世界胃肠病学杂志(英文版)
  • 相关文献

参考文献11

  • 1Lishman AH, A1-Jumaili IJ, Record CO. Spectrum of antibioticassociated diarrhoea. Gut 1981; 22:34-37.
  • 2Bergstein JM, Kramer A, Wittman DH, Aprahamian C,Quebbeman EJ. Pseudomembranous colitis: how useful is endoscopy? Surg Endosc 1990; 4:217-219.
  • 3Totten MA, Gregg JA, Fremont-Smith P, Legg M. Clinical and pathological spectrum of antibiotic-associated colitis. Am J Gastroenterol 1978:69(3 Pt 1): 311-319.
  • 4Gerding DN, Olson MM, Peterson LR, Teasley DG, Gebhard RL,Schwartz ML, Lee JT Jr. Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic stuffy. Arch Intern Med 1986: 146:95-100.
  • 5Klingler PJ, Metzger PP, Seelig MH, Pettit PD, Knudsen JM,Alvarez SA. Clostridium difficile infection: risk factors, medical and surgical management. Dig Dis 2000; 18:147-160.
  • 6Santini G, Contu A, Porcellini A, Chisesi T, Coser P, Congiu AM,Morandi S, Manna A, Schintu GM, Quanini R, Rancan L, Miglio L, Damasio E, Rizzoli V. Mitoxantrone alone or in combination chemotherapy (VeMP) as second-line treatment in relapsed or refractory poor-prognoMs non-Hodgkin's lymphoma. A report of the Non-Hodgkin's Lymphoma Co-operative Study Group (NHLCSG). Haematologica 1991; 76:485-490.
  • 7de Lalla F, Privitera G, Rinaldi E, Ortisi G, Santoro D, Rizzardini G. Treatment of Clostridium difficile-associated disease with teicoplanin. Antimicrob Agents Chemother 1989; 33:1125-1127.
  • 8Wenisch C, Parschalk B, Hasenhundl M, Hirschl AM, Graninger W. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis 1996; 22:813-818.
  • 9O'Connor RP, Silva J Jr, Fekety R. Rifampicin and antibiotic-associated colitis. Lancet 1981; 1:499.
  • 10Ripa S, Mignini F, Prenna M, Falcioni E. In vitro antibacterial activity of rifaximin against Clostridium difficile, Campylobacter jejunii and Yersinia spp. Drugs Exp Clin Res 1987; 13:483-488.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部